Parenteral iron nephrotoxicity: Potential mechanisms and consequencesZAGER, Richard A; JOHNSON, Ali C. M; HANSON, Sherry Y et al.Kidney international. 2004, Vol 66, Num 1, pp 144-156, issn 0085-2538, 13 p.Article

Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconateSANE, Radhika; BARIBEAULT, David; ROSENBERG, Carol L et al.Pharmacotherapy. 2007, Vol 27, Num 4, pp 613-615, issn 0277-0008, 3 p.Article

Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney diseaseAGARWA, R; RIZKALA, A. R; KASKAS, M. O et al.Kidney international. 2007, Vol 72, Num 5, pp 638-642, issn 0085-2538, 5 p.Article

Physicochemical and toxicological characterization of a new generic iron sucrose preparationMEIER, Thomas; SCHROPP, Patricia; PATER, Christian et al.Arzneimittel-Forschung. 2011, Vol 61, Num 2, pp 112-119, issn 0004-4172, 8 p.Article

Intravenous iron as adjuvant therapy: a two-edged sword?CAVILL, Ivor.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, pp viii24-viii28, issn 0931-0509, SUP8Conference Paper

Risk of infection with intravenous iron therapyMAYNOR, Lena; BROPHY, Donald F.The Annals of pharmacotherapy. 2007, Vol 41, Num 9, pp 1476-1480, issn 1060-0280, 5 p.Article

Effect of iron sucrose on human peritoneal mesothelial cellsBREBOROWICZ, M; POLUBINSKA, A; TAM, P et al.European journal of clinical investigation. 2003, Vol 33, Num 12, pp 1038-1044, issn 0014-2972, 7 p.Article

Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complexBREYMANN, Christian; VON SEEFRIED, Bettina; STAHEL, Michele et al.Journal of perinatal medicine. 2007, Vol 35, Num 2, pp 115-118, issn 0300-5577, 4 p.Article

A Comparative Look at the Safety Profiles of Intravenous Iron Products Used in the Hemodialysis PopulationCOPPOL, Elena; SHELLY, Jamie; CHENG, Stephanie et al.The Annals of pharmacotherapy. 2011, Vol 45, Num 2, pp 241-247, issn 1060-0280, 7 p.Article

Do two intravenous iron sucrose preparations have the same efficacy?ROTTEMBOURG, Jacques; KADRI, Ahmed; LEONARD, Emmanuelle et al.Nephrology, dialysis, transplantation (Print). 2011, Vol 26, Num 10, pp 3262-3267, issn 0931-0509, 6 p.Article

Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trialMCMAHON, Lawrence P; KENT, Annette B; KERR, Peter G et al.Nephrology, dialysis, transplantation (Print). 2010, Vol 25, Num 3, pp 920-926, issn 0931-0509, 7 p.Article

Impact of iron sucrose therapy on leucocyte surface molecules and reactive oxygen species in haemodialysis patientsGUZ, Galip; GLORIEUX, Griet L; DE SMET, Rita et al.Nephrology, dialysis, transplantation (Print). 2006, Vol 21, Num 10, pp 2834-2840, issn 0931-0509, 7 p.Article

A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemiaWESTAD, Stian; BACKE, Bjørn; SALVESEN, Kjell Asmund et al.Acta obstetricia et gynecologica Scandinavica. 2008, Vol 87, Num 9, pp 916-923, issn 0001-6349, 8 p.Article

Chemical reactions of vitamin C with intravenous-iron formulationsSUXIN WANG; GERACI, Gina; KUHLMANN, Martin K et al.Nephrology, dialysis, transplantation (Print). 2008, Vol 23, Num 1, pp 120-125, issn 0931-0509, 6 p.Article

Chronic use of sodium ferric gluconate complex in hemodialysis patients: Safety of higher-dose (≥250 mg) AdministrationFOLKERT, Vaughn W; MICHAEL, Beckie; AGARWAL, Rajiv et al.American journal of kidney diseases. 2003, Vol 41, Num 3, pp 651-657, issn 0272-6386, 7 p.Article

Safety in iron managementFISHBANE, Steven.American journal of kidney diseases. 2003, Vol 41, Num 6, pp S18-S26, issn 0272-6386, SUP5Article

Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucroseCHRISTOPH, Patricia; SCHULLER, Christine; STUDER, Hanna et al.Journal of perinatal medicine. 2012, Vol 40, Num 5, pp 469-474, issn 0300-5577, 6 p.Article

Modulation of Pseudomonas aeruginosa lipopolysaccharide-induced lung inflammation by chronic iron overload in ratVUONG LE, Bá; KHORSI-CAUET, Hafida; BACH, Véronique et al.FEMS immunology and medical microbiology (Print). 2012, Vol 64, Num 2, pp 255-264, issn 0928-8244, 10 p.Article

Management of iron deficiency in patients admitted to hospital : time for a rethink of treatment principlesAHMAD, I; GIBSON, P. R.Internal medicine journal (Print). 2006, Vol 36, Num 6, pp 347-354, issn 1444-0903, 8 p.Article

Trends in intravenous iron use among dialysis patients in the United States (1994-2002)PETER, Wendy L. St; OBRADOR, Gregorio T; ROBERTS, Tricia L et al.American journal of kidney diseases. 2005, Vol 46, Num 4, pp 650-660, issn 0272-6386, 11 p.Article

Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysisPAI, Amy Barton; BOYD, Alex V; MCQUADE, Charles R et al.Pharmacotherapy. 2007, Vol 27, Num 3, pp 343-350, issn 0277-0008, 8 p.Article

Update on adverse drug events associated with parenteral ironCHERTOW, Glenn M; MASON, Phillip D; VAAGE-NILSEN, Odd et al.Nephrology, dialysis, transplantation (Print). 2006, Vol 21, Num 2, pp 378-382, issn 0931-0509, 5 p.Article

Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysisMCMAHON, Lawrence P; CHESTER, Kate; WALKER, Rowan G et al.American journal of kidney diseases. 2004, Vol 44, Num 3, pp 509-516, issn 0272-6386, 8 p.Article

Labile iron in parenteral iron formulations: a quantitative and comparative studyVAN WYCK, David; ANDERSON, Jaime; JOHNSON, Kevin et al.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, Num 3, pp 561-565, issn 0931-0509, 5 p.Article

Hypersensitivity reactions and deaths associated with intravenous iron preparationsBAILIE, George R; CLARK, John A; LANE, Christi E et al.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, Num 7, pp 1443-1449, issn 0931-0509, 7 p.Article